Molecular Templates, Inc. (NASDAQ: MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Comments

Molecular Templates (MTEM) Prices 8.2M Share Common Offering at $5.50/ShSeptember 21, 2018 5:45 AM Molecular Templates (MTEM) Announces Proposed Common Share OfferingSeptember 19, 2018 4:02 PM Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology TherapySeptember 19, 2018 8:00 AM